Profession Notes

The Stowers Institute for Medical Research recently received an additional gift of $1.1 billion in securities from Jim and Virginia Stowers, who founded the Kansas City, Mo., research facility in 1998 (S. Bunk, "Big Plans for Kansas City," The Scientist 14[23]:14, Nov. 27, 2000). Their latest contribution raises the total value of the institute's endowment above $1.6 billion. The Stowers family originally intended for this gift to pass to the institute following their deaths, but by giving it no

Written byMaria Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The Stowers Institute for Medical Research recently received an additional gift of $1.1 billion in securities from Jim and Virginia Stowers, who founded the Kansas City, Mo., research facility in 1998 (S. Bunk, "Big Plans for Kansas City," The Scientist 14[23]:14, Nov. 27, 2000). Their latest contribution raises the total value of the institute's endowment above $1.6 billion. The Stowers family originally intended for this gift to pass to the institute following their deaths, but by giving it now they hope to boost recruitment of scientists. The nonprofit medical research organization began work last November with three researchers under the supervision of president William Neaves and scientific director Richard Krumlauf. Two researchers and several administrators joined the already existing staff in December; four more primary researchers came on board in March, bringing the total number of senior scientists to nine. Recruitment is still under way: The $200 million, 600,000-square-foot campus can house 50-60 research programs, each with a team of five to 10 researchers and lab technicians. By the fall of 2002, the institute hopes to have 16 working laboratories. The sale of 45 percent of American Century Cos.--a national investment management firm founded by Jim Stowers in 1958--to J.P. Morgan in early 1998 added to the initial funds of $50 million, given to the institute in 1994.

A Web of Integrity

To unveil affiliations between scientists and businesses, the Center for Science in the Public Interest (CSPI) recently launched a Web site entitled Integrity in Science (www.integrityinscience.org). Compiled from résumés, news articles, other Web sites, conference programs, and other public references, the site provides information about relationships between scientists and corporations, including information about funding the scientists may have received (see also, K. Kreeger, P. Park, "When Corporations Pay for Research," The Scientist, 15 [11]: May 28, 2001). Concerned that scientists do not always disclose the corporate sponsors of their work, CSPI hopes this database will be "a starting point, a useful resource that will encourage journalists to routinely ask about possible conflicts of interest," according to executive director Michael Jacobson. "Right now we have about 1,100 names in the database, but we hope to increase that. We would like to expand our coverage, especially in areas concerning environmental issues" related to human health, such as the use of toxic chemicals. The Integrity in Science database is the most recent in a series of health-related resources provided by CSPI, a nonprofit advocacy group started in Washington, D.C. in 1971.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies